Use of peptides
CA 2391872 A1 · Owner: Takeda Chemical Industries, Ltd. · Inventors: Hinuma, Shuji; Matsumoto, Hirokazu; Kitada, Chieko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A ligand and a peptide having an effect of controlling the secretion of CRH which are useful as CRH secretion controlling agents or analgesics in ameliorating, preventing and treating various diseases concerning the CRH secretion such as hypoaldosteronism, hypocortisolemia secondary and chronic , hypoadrenocorticism Addison's disease (boredom, nausea, pigmentation hypogonadism, hair removal, hypotension) adrenal gland hypofunction and , obesity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.